RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 12-22
  • Sanford-Burnham taps new CEO from pharma industry

    Sanford-Burnham taps new CEO from pharma industry
    With the selection of Perry Nisen as its new chief executive officer today, Sanford-Burnham Medical Research Institute is signaling a commitment to its new long-term strategic vision of open collaboration for the development of breakthrough clinical...
  • U.S. clears AstraZeneca over heart drug trial

    LONDON (Reuters) - The U.S. government has cleared AstraZeneca Plc over a major clinical trial used to win marketing approval for its important new heart drug Brilinta, following an investigation which had cast a shadow over its prospects. The drugmaker...
  • Connecticut Growers Tending Marijuana Crops, Preparing For Sales Starting In September

    Connecticut Growers Tending Marijuana Crops, Preparing For Sales Starting In September
    For months, Advanced Grow Labs LLC — one of Connecticut's four medical marijuana growing companies — slogged through the process of competing for a state license, securing local zoning approvals, and outfitting a building to state...
  • 'Plantibodies' drugs advance as big pharma stands aside

    LOS ANGELES (Reuters) - Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical companies. The leading...
  • SEC is investigating bid by Valeant and Bill Ackman for Allergan

    The Securities and Exchange Commission is looking into the way a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine. Word of the investigation came less than a week after Allergan sued...
  • FDA seeks more data on Acura's abuse-resistant pain drug

    (Reuters) - Acura Pharmaceuticals Inc said the U.S. Food and Drug Administration (FDA) indicated that the company may have to conduct an additional study to determine the abuse-deterrent capability of its experimental painkiller treatment. The FDA in...
  • Top hedge funds flocked to Allergan amid bid backed by Ackman

    BOSTON (Reuters) - Billionaire investor William Ackman, who often says he is flattered when others follow him into a stock he likes, was joined by several prominent hedge funds that made new bets on takeover target Allergan Inc during the second quarter....
  • SEC reviewing attempted takeover of Botox maker Allergan

    The Securities and Exchange Commission is looking into the way that a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine. Ackman's hedge fund, Pershing Square Capital Management,...
  • Cohen, Point72 must face SAC insider trading lawsuit-judge

    NEW YORK (Reuters) - A federal judge rejected billionaire investor Steven A. Cohen's bid to dismiss lawsuits by Elan Corp and Wyeth shareholders who claimed they lost money because his firm SAC Capital Advisors LP conducted insider trading in the...
  • FDA approves Belsomra, a new prescription sleep drug

    FDA approves Belsomra, a new prescription sleep drug
    The Food & Drug Administration on Wednesday approved U.S. marketing of the first in a new class of sleep drugs that targets the brain's wakefulness centers to speed the onset of sleep and reduce nighttime awakening. The new medication, which goes by the...
  • Top U.S. lawmaker urges Hospira not to flee tax system

    WASHINGTON (Reuters) - A senior U.S. senator said on Thursday he has written to Hospira Inc and urged the drug and medical device maker not to move its tax domicile abroad to save on U.S. taxes. Citing recent reports that Hospira plans to buy the medical...